Review: To what extent are T cells tolerant to immunoglobulin variable regions?

Scandinavian Journal of Immunology

Volumn 70, Issue 6, 2009, Pages 526-530

  Bogen, B ^a   Ruffini, P ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; PEPTIDE;

B LYMPHOCYTE; CONCENTRATION (PARAMETERS); GENETICS; GERM LINE; HUMAN; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOSURVEILLANCE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SOMATIC HYPERMUTATION; T LYMPHOCYTE; VACCINATION;

ANIMALS; ANTIGEN-PRESENTING CELLS; B-LYMPHOCYTES; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNE TOLERANCE; IMMUNOGLOBULIN IDIOTYPES; IMMUNOGLOBULIN VARIABLE REGION; T-LYMPHOCYTE SUBSETS;

EID: 70450081797     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2009.02340.x     Document Type: Review

References (52)

1. Tonegawa S. Somatic generation of antibody diversity. Nature 1983 302 : 575 581.
2. Kristoffersen G, Hannestad K, Hansen T. Two M315 idiotopes defined by isologous monoclonal antibodies: one depends on germline and the other on mutated murine lambda 2 light chain sequences. Scand J Immunol 1987 26 : 535 546.
3. Sirisinha S, Eisen HN. Autoimmune-like antibodies to the ligand-binding sites of myeloma proteins. Proc Natl Acad Sci USA 1971 68 : 3130 3135.
4. Jerne NK. Towards a network theory of the immune system. Ann Immunol (Paris) 1974 125C : 373 389.
5. Bogen B, Malissen B, Haas W. Idiotope-specific T cell clones that recognize syngeneic immunoglobulin fragments in the context of class II molecules. Eur J Immunol 1986 16 : 1373 1378.
6. Bogen B, Snodgrass R, Briand JP, Hannestad K. Synthetic peptides and beta-chain gene rearrangements reveal a diversified T cell repertoire for a lambda light chain third hypervariable region. Eur J Immunol 1986 16 : 1379 1384.
7. Bogen B, Lambris JD. Minimum length of an idiotypic peptide and a model for its binding to a major histocompatibility complex class II molecule. EMBO J 1989 8 : 1947 1952.
8. Saeki Y, Chen JJ, Shi LF, Okuda Y, Kohler H. Idiotype-specific T helper clones recognize a variable H chain determinant. J Immunol 1990 144 : 1625 1628.
9. Weiss S, Bogen B. B-lymphoma cells process and present their endogenous immunoglobulin to major histocompatibility complex-restricted T cells. Proc Natl Acad Sci USA 1989 86 : 282 286.
10. Weiss S, Bogen B. MHC class II-restricted presentation of intracellular antigen. Cell 1991 64 : 767 776.
11. Munthe LA, Kyte JA, Bogen B. Resting small B cells present endogenous immunoglobulin variable-region determinants to idiotope-specific CD4(+) T cells in vivo. Eur J Immunol 1999 29 : 4043 4052.
12. Snyder CM, Zhang X, Wysocki LJ. Negligible class II MHC presentation of B cell receptor-derived peptides by high density resting B cells. J Immunol 2002 168 : 3865 3873.
13. Bogen B, Weiss S. Processing and presentation of idiotypes to MHC-restricted T cells. Int Rev Immunol 1993 10 : 337 355.
14. Singh RR, Hahn BH. Reciprocal T-B determinant spreading develops spontaneously in murine lupus: implications for pathogenesis. Immunol Rev 1998 164 : 201 208.
15. Zhang X, Smith DS, Guth A, Wysocki LJ. A receptor presentation hypothesis for T cell help that recruits autoreactive B cells. J Immunol 2001 166 : 1562 1571.
16. Munthe LA, Os A, Zangani M, Bogen B. MHC-restricted Ig V region-driven T-B lymphocyte collaboration: B cell receptor ligation facilitates switch to IgG production. J Immunol 2004 172 : 7476 7484.
17. Snyder CM, Aviszus K, Heiser RA, Tonkin DR, Guth AM, Wysocki LJ. Activation and tolerance in CD4(+) T cells reactive to an immunoglobulin variable region. J Exp Med 2004 200 : 1 11.
18. Munthe LA, Corthay A, Os A, Zangani M, Bogen B. Systemic autoimmune disease caused by autoreactive B cells that receive chronic help from Ig V region-specific T cells. J Immunol 2005 175 : 2391 2400.
19. Zangani M, Carlsen H, Kielland A et al. Tracking early autoimmune disease by bioluminescent imaging of NF-kappaB activation reveals pathology in multiple organ systems. Am J Pathol 2009 174 : 1358 1367.
20. Zangani MM, Froyland M, Qiu GY et al. Lymphomas can develop from B cells chronically helped by idiotype-specific T cells. J Exp Med 2007 204 : 1181 1191.
21. Williams WM, Staines NA, Muller S, Isenberg DA. Human T cell responses to autoantibody variable region peptides. Lupus 1995 4 : 464 471.
22. Dayan M, Segal R, Sthoeger Z et al. Immune response of SLE patients to peptides based on the complementarity determining regions of a pathogenic anti-DNA monoclonal antibody. J Clin Immunol 2000 20 : 187 194.
23. van Schooten WC, Devereux D, Ho CH, Quan J, Aguilar BA, Rust CJ. Joint-derived T cells in rheumatoid arthritis react with self-immunoglobulin heavy chains or immunoglobulin-binding proteins that copurify with immunoglobulin. Eur J Immunol 1994 24 : 93 8.
24. Holmoy T, Fredriksen AB, Thompson KM, Hestvik AL, Bogen B, Vartdal F. Cerebrospinal fluid T cell clones from patients with multiple sclerosis: recognition of idiotopes on monoclonal IgG secreted by autologous cerebrospinal fluid B cells. Eur J Immunol 2005 35 : 1786 1794.
25. Hestvik AL, Vartdal F, Fredriksen AB et al. T cells from multiple sclerosis patients recognize multiple epitopes on Self-IgG. Scand J Immunol 2007 66 : 393 401.
26. Lauritzsen GF, Weiss S, Dembic Z, Bogen B. Naive idiotype-specific CD4 + T cells and immunosurveillance of B-cell tumors. Proc Natl Acad Sci U S A 1994 91 : 5700 5704.
27. Dembic Z, Schenck K, Bogen B. Dendritic cells purified from myeloma are primed with tumor-specific antigen (idiotype) and activate CD4 + T cells. Proc Natl Acad Sci USA 2000 97 : 2697 2702.
28. Corthay A, Skovseth DK, Lundin KU et al. Primary antitumor immune response mediated by CD4 + T cells. Immunity 2005 22 : 371 383.
29. Corthay A, Lundin KU, Lorvik KB, Hofgaard PO, Bogen B. Secretion of tumor-specific antigen by myeloma cells is required for cancer immunosurveillance by CD4 + T cells. Cancer Res 2009 69 : 5901 5907.
30. George AJ, Folkard SG, Hamblin TJ, Stevenson FK. Idiotypic vaccination as a treatment for a B cell lymphoma. J Immunol 1988 141 : 2168 2174.
31. Campbell MJ, Esserman L, Byars NE, Allison AC, Levy R. Idiotype vaccination against murine B cell lymphoma. Humoral and cellular requirements for the full expression of antitumor immunity. J Immunol 1990 145 : 1029 1036.
32. Bendandi M. Idiotype vaccines for lymphoma: proof-of-principles and clinical trial failures. Nat Rev Cancer 2009 9 : 675 681.
33. Bogen B, Weiss S, Dembic Z. Idiotypes and T cell selection. In : Kresina T, ed. Handbook of Immune Modulating Agents. New York : Marcel Decker, 1997 : 35 54.
34. Bogen B, Jorgensen T, Hannestad K. T helper cell recognition of idiotopes on lambda 2 light chains of M315 and T952: evidence for dependence on somatic mutations in the third hypervariable region. Eur J Immunol 1985 15 : 278 281.
35. Eyerman MC, Wysocki L. T cell recognition of somatically-generated Ab diversity. J Immunol 1994 152 : 1569 1577.
36. Eyerman MC, Zhang X, Wysocki LJ. T cell recognition and tolerance of antibody diversity. J Immunol 1996 157 : 1037 1046.
37. Snodgrass HR, Fisher AM, Bruyns E, Bogen B. Restricted alpha/beta receptor gene usage of idiotype-specific major histocompatibility complex-restricted T cells: selection for CDR3- related sequences. Eur J Immunol 1992 22 : 2169 2172.
38. Bogen B, Dembic Z, Weiss S. Clonal deletion of specific thymocytes by an immunoglobulin idiotype. EMBO J 1993 12 : 357 363.
39. Bogen B, Gleditsch L, Weiss S, Dembic Z. Weak positive selection of transgenic T cell receptor-bearing thymocytes: importance of major histocompatibility complex class II, T cell receptor and CD4 surface molecule densities. Eur J Immunol 1992 22 : 703 709.
40. Bogen B, Weiss S. A rearranged lambda 2 light gene chain retards but does not exclude kappa and lambda 1 expression. Eur J Immunol 1991 21 : 2391 2395.
41. Faure M, Sanchez P, Cazenave PA, Rueff-Juy D. T cell tolerance to kappa light chain (L kappa): identification of a naturally processed self-C kappa-peptidic region by specific CD4 + T cell hybridomas obtained in L kappa-deficient mice. Cell Immunol 1997 180 : 84 92.
42. Faure M, Calbo S, Kanellopoulos J, Drapier AM, Cazenave PA, Rueff-Juy D. Tolerance to maternal immunoglobulins: resilience of the specific T cell repertoire in spite of long-lasting perturbations. J Immunol 1999 163 : 6511 6519.
43. Cao W, Myers-Powell BA, Braciale TJ. Recognition of an immunoglobulin VH epitope by influenza virus-specific class I major histocompatibility complex-restricted cytolytic T lymphocytes. J Exp Med 1994 179 : 195 202.
44. Cao W, Tykodi SS, Esser MT, Braciale VL, Braciale TJ. Partial activation of CD8 + T cells by a self-derived peptide. Nature 1995 378 : 295 298.
45. Cao W, Myers-Powell BA, Braciale TJ. The weak CD8 + CTL response to an influenza hemagglutinin epitope reflects limited T cell availability. J Immunol 1996 157 : 505 511.
46. Rueff-Juy D, Sanchez P, Faure M, Drapier AM, Cazenave PA. Emergence in C kappa knockout mice of a diverse cytotoxic T lymphocyte repertoire that recognizes a single peptide from the immunoglobulin constant kappa light chain region. Eur J Immunol 1995 25 : 2752 2756.
47. Rueff-Juy D, Faure M, Drapier AM, Cazenave PA. Role of maternal Ig in the induction of C kappa-specific CD8 + T cell tolerance. J Immunol 1998 161 : 721 728.
48. Lauritzsen GF, Hofgaard PO, Schenck K, Bogen B. Clonal deletion of thymocytes as a tumor escape mechanism. Int J Cancer 1998 78 : 216 222.
49. Bogen B. Peripheral T cell tolerance as a tumor escape mechanism: deletion of CD4 + T cells specific for a monoclonal immunoglobulin idiotype secreted by a plasmacytoma. Eur J Immunol 1996 26 : 2671 2679.
50. Blichfeldt E, Munthe LA, Rotnes JS, Bogen B. Dual T cell receptor T cells have a decreased sensitivity to physiological ligands due to reduced density of each T cell receptor. Eur J Immunol 1996 26 : 2876 2884.
51. Hansson L, Rabbani H, Fagerberg J, Osterborg A, Mellstedt H. T-cell epitopes within the complementarity-determining and framework regions of the tumor-derived immunoglobulin heavy chain in multiple myeloma. Blood 2003 101 : 4930 4936.
52. Lou Q, Kelleher RJ Jr., Sette A et al. Germ line tumor-associated immunoglobulin VH region peptides provoke a tumor-specific immune response without altering the response potential of normal B cells. Blood 2004 104 : 752 759.